The number of stem cell transplantation performed in Canada has shown a consistent increase over the past decade, reaching 2.68 thousand inpatient cases in 2023. From 2013 to 2023, the Compound Annual Growth Rate (CAGR) varied, with more significant growth in earlier years; for instance, the CAGR was 5.92% in 2013, showing robust activity early on. The past two years showed moderate growth with year-on-year variations of 2.67% in 2022 and 2.56% in 2023.
From 2024 onwards, the forecast indicates continued growth, albeit at a slightly slower pace, with an expected 1.82% CAGR over the next five years, culminating in a 9.43% growth by 2028.
Future trends to watch for include advancements in medical technology, which could potentially increase the success rates and scope of stem cell transplantation. Additionally, policy changes or funding improvements for healthcare can impact the number of procedures performed. Attention should also be given to demographic trends and the incidence of diseases that require stem cell transplants.
